Pyxis Oncology raises $152m in Series B round for cancer therapies

pallavi123- March 30, 2021 0

Pyxis Oncology, a Boston-based biotech company, has raised $152 million in a Series B financing round co-led by Arix Bioscience and RTW Investments. The company ... Read More